Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Completed 4

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Conditions

Polycystic Ovary Syndrome 4Infertility 3Helping Behavior 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × INDUSTRY × follitropin alfa × Clear all
NCT02607293 2018-06-28

ARTIST

Merck KGaA, Darmstadt, Germany

Completed
1,064 enrolled

Polycystic Ovary Syndrome

NCT01081639 2014-07-31

To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
34 enrolled

Infertility, Polycystic Ovary Syndrome

NCT01081626 2014-02-13

Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction

Merck KGaA, Darmstadt, Germany

Phase 4 Completed
310 enrolled 18 charts

Infertility, Polycystic Ovary Syndrome

NCT01185782 2013-12-27

SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women

Merck KGaA, Darmstadt, Germany

Phase 3 Completed
300 enrolled 18 charts

Helping Behavior, Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡